Trials / Completed
CompletedNCT02121197
Retrospective Trial on the Efficacy and Safety of Intravitreal Ozurdex in Patients With Diabetic Macular Edema.
A Collaborative Retrospective Trial on the Efficacy and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients With Diabetic Macular Edema (DME). THE EUROPEAN DME REGISTRAR STUDY (ARTES)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 321 (actual)
- Sponsor
- Association for Innovation and Biomedical Research on Light and Image · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To review the safety and efficacy of injections with Ozurdex (700 μg dexamethasone) in clinical practice management of patients with DME.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ozurdex |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2016-01-01
- Completion
- 2016-01-01
- First posted
- 2014-04-23
- Last updated
- 2018-05-21
Locations
25 sites across 8 countries: Finland, France, Israel, Italy, Portugal, Spain, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT02121197. Inclusion in this directory is not an endorsement.